PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients
Public ClinicalTrials.gov record NCT05447637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center Prospective Observational Study of Community Urology Practices Applying Germline Genetic Testing for Prostate Cancer Patients (PROCLAIM)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This registry is for men who have prostate cancer and have had multigene panel hereditary testing. The registry will gather data on genetic testing results and how that information may change physician treatment or follow up recommendations. It will also gather data on the patient's experience with genetic testing, through a post-test survey to be completed 60-90days after results have been received and discussed with their provider.
Study identification
- NCT ID
- NCT05447637
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2019
- Primary completion
- Jun 30, 2021
- Completion
- May 30, 2022
- Last update posted
- Jul 6, 2022
2019 – 2022
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Healthcare Partners | San Diego | California | 92123 | — |
| Invitae | San Francisco | California | 94103 | — |
| Department of Bioengineering and Therapeutic Sciences, University of California San Francisco | San Francisco | California | 94158 | — |
| Volunteer Faculty, University of California San Francisco | San Francisco | California | 94158 | — |
| Colorado Urology | Lakewood | Colorado | 80228 | — |
| Advanced Urology Institute | St. Petersburg | Florida | 33710 | — |
| Florida Urology Partners | Tampa | Florida | 33606 | — |
| TGH Cancer Institute | Tampa | Florida | 33606 | — |
| North Georgia Urology | Dalton | Georgia | 30720 | — |
| Associated Urological Specialists | Chicago Ridge | Illinois | 60415 | — |
| University Urology Associates of New Jersey | Hamilton | New Jersey | 08690 | — |
| Perlmutter Cancer Center, NYU Langone Health, New York | New York | New York | 10016 | — |
| Associated Medical Professionals | Syracuse | New York | 13210 | — |
| MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Associates, P.C. | Nashville | Tennessee | 37211 | — |
| Urology Partners | Arlington | Texas | 76017 | — |
| Urology Austin | Austin | Texas | 78759 | — |
| Urosurgery Houston | Houston | Texas | 77002 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05447637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 6, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05447637 live on ClinicalTrials.gov.